Pirtobrutinib and venetoclax combination overcomes resistance to targeted and chimeric antigen receptor T-cell therapy in aggressive mantle cell lymphoma.Yang Liu,Fangfang Yan,Vivian Changying Jiang,Yijing Li,Yuxuan Che,Joseph McIntosh,Alexa Jordan, Ian Hou,Lei Nie,Jingling Jin,Wei Wang,Heng-Huan Lee,Yixin Yao,Michael WangHaematologica(2023)引用 0|浏览9暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要